Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses <i>in Vitro</i> and <i>in Vivo</i>
2013 · ACS Nano · 618 citations
https://doi.org/10.1021/nn3057005
T
Tadaki Suzuki
Chiba University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
404
Papers
16.8K
Citations
59
h-index
187
i10-index
Tadaki Suzuki is an academic researcher from Chiba University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 59, co-authored 344 publications.
ORCID: 0000-0002-3820-9542Papers by this author
worksSARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
2021 · Nature Communications · 536 citations
https://doi.org/10.1038/s41467-021-21118-2
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
2021 · iScience · 181 citations
https://doi.org/10.1016/j.isci.2021.102367
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
2022 · Nature · 106 citations
https://doi.org/10.1038/s41586-022-05482-7
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
2021 · Immunity · 75 citations
https://doi.org/10.1016/j.immuni.2021.08.025
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses
2022 · Cell Reports Medicine · 59 citations
https://doi.org/10.1016/j.xcrm.2022.100520
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat